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ABSTRACT
Objective: The objective of this study is to investigate the effect of light-roasted green coffee bean extract (GCE) administration for 7 weeks on the 
improvement of metabolic profile, adiponectin level, homeostatic model assessment insulin resistance (HOMA-IR) index in metabolic syndrome (MS) 
rat model.
Methods: Adult male Sprague-Dawley rats were induced by a combination of high sucrose and high-fat diet for 8 weeks and streptozotocin injection in 
the 2nd week. The MS was confirmed by NCEP-ATP III criteria. They were divided into six weight-matched groups (n=5), normal control, MS, metformin 
and simvastatin-treated group (DMS), 100 and 200/body weight (bw) GCE (GCE 100 and GCE 200, respectively). The extracts were given through oral 
gavage daily for 7 weeks. The effect of GCE on body weight, serum glucose, triglyceride, (TG) and high-density lipoprotein (HDL) level was analyzed by 
colorimetric method. HOMA-IR index and adiponectin were analyzed by enzyme-linked immunosorbent assay methods.
Result: Fasting blood glucose, TG, and systolic blood pressure decreased significantly (p<0.05) in both GCE groups. Moreover, after 7 weeks, those 
parameters were significantly lower (p<0.05) compared to that of MS group. Only GCE 100 group that showed a significant decrease in HDL level. GCE 
100 mg/bw and 200 mg/bw group showed significantly higher adiponectin level compared to that of MS and DMS group. Furthermore, GCE 100, GCE 
200, and DMS group showed a significant lower HOMA-IR index compared to that of MS group.
Conclusion: 7 weeks GCE administration could decrease fasting blood glucose, profile lipid, blood pressure, and improved adiponectin level and 
HOMA-IR index.
Keywords: Metabolic syndrome, Green coffee bean extract, Adiponectin, Homeostatic model assessment insulin resistance.
INTRODUCTION
Metabolic syndrome (MS) is a complex, multifactor disorder that 
increases the risk of cardiovascular diseases and diabetes mellitus 
Type 2. MS prevalence was around 10-84% based on age, gender, 
race, ethnicity, and MS criteria [1]. The World Health Organization, 
International Diabetes Federation, and National Cholesterol of Adult 
Treatment Panel III have determined specific criteria of MS which 
included central obesity, high blood pressure, high triglyceride (TG) 
levels, low high-density lipoprotein (HDL), and high glucose levels [2]. 
Currently, there is no single treatment for MS, and interest in natural 
products as potential treatments has increased [3].
Coffee, one of the most widely consumed beverages in the world has 
attracted a great public interest on its potential health consequences [4]. 
Coffee has many bioactive components, including caffeine, polyphenols, 
phenolic acids, and micronutrients. Some epidemiological studies 
suggested that high phenolic content foods and drinks consumption 
would prevent coronary artery disease, cancer, and so on [5,6]. 
Chlorogenic acid (CGA) as the most abundant phenolic acid found in 
green coffee bean may exert antidiabetic, antihyperlipidemia, and 
antiobesity [7-9] effects. Animal experiments suggested that green 
coffee bean extract (GCE) rich CGA have beneficial effects on glucose 
and lipid metabolism disorders in high-fat diet (HFD)-induced mice and 
rats and can also improve insulin sensitivity in genetically predisposed 
animals [10]. The effect of GCE could be increased by roasting process. 
The previous study suggested that light-roasting process resulted 
in higher anti-oxidant activity of CGA in GCE [11]. Hence, this study 
used light roasted coffee beans to make it a novel source of CGAs and 
eliminating the possible side effects of caffeine.
The effect of coffee consumption on MS improvement was still debated. 
A study by Cheong et al. revealed that GCE administration for 12 weeks 
did not attenuate HFD-induced obesity, glucose intolerance, insulin 
resistance (IR), and systemic oxidative stress in C5BL6 mice [12]. 
Conversely, Song et al. revealed that decaffeinated GCE attenuated HFD-
induced fat accumulation and IR in male C57BL/LN mice [13]. However, 
there was no prior study that conducted in MS rat model.
Adiponectin, the most abundant circulating adipokine, is a critical 
regulator of insulin sensitivity [14], tissue inflammation [15], and 
lipid metabolism [16]. Therefore, adiponectin is considered as an 
important MS biomarker and therapeutic target [17,18]. The effect 
of GCE administration on adiponectin level and consequently on 
the improvement of homeostatic model assessment-IR (HOMA-
IR) index, lipid profile, fasting blood glucose level, and systolic 
blood pressure (SBP) in MS rat model was still unknown. Thus, this 
study investigated the effect of light-roasted GCE administration 
on those therapeutic targets. To the extent of our knowledge, this 
is the first study revealed the beneficial effect of light-roasted GCE 
administration on the improvement of adiponectin level, HOMA-IR 
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index, lipid profile, fasting blood glucose level, and SBP in MS rat 
model.
METHODS
Extraction of green coffee bean
Coffee was extracted from light roasted robusta green coffee beans 
(Temanggung, Indonesia). Green coffee bean was sorted to obtain 
high-quality seed. Green coffee bean weighed 500 g was dried using a 
dryer cabinet on the temperature of 50°C for 8 h to obtain simplicia 
with 8-10% water content. The simplicia was mashed with a blender 
and thenmacerated by methanol to produce crude extract. The crude 
extract was filtered using a filter cloth to separate the liquid phase 
from the solid phase. The liquid phase was concentrated using rotary 
evaporator on temperature ±40°C. The concentrated liquid phase was 
partitioned using butanol, water, and acetylacetonate. Finally, column 
chromatography was completed using silica gel as static phase, and the 
filtered product was evaporated.
Animal care and experimental protocol
25 Sprague-Dawley rats were purchased from the National Agency of 
Drug and Food Control, Indonesia. They were housed in standard cages 
and placed in a room where the temperature was maintained at 25±1°C, 
relative humidity at 50±1%, and the light at a 12 hrs light/dark cycle. 
During a 1-week acclimatization period, all rats consumed a normal 
pellet diet and tap water ad libitum. Afterward, they received high 
sucrose, HFD, and high sodium diet for 8 weeks and intraperitoneal 
streptozotocin injection (30 mg/body weight [bw]) in the 2nd week. The 
injection was repeated in the 3rd week with the same dose. The rats with 
blood glucose (>126 mg/dL), TG (>150 mg/dL), high SBP (≥140 mmHg), 
and reduced HDL levels (<40 mg/dL) was confirmed as MS rat based 
on NCEP-ATP III criteria [2]. Furthermore, they were divided into six 
weight-matched groups (n=5): The normal control (NC), MS, MS with 
metformin 200 mg/bw and simvastatin 10 mg/kg body weight (DMS), 
100 and 200/bw GCE (GCE 100 and GCE 200, respectively). The extract 
was given through oral gavage daily. Extract dose was given in milliliters 
based on the body weight measured weekly. The food and water 
intake was recorded daily. At the end of the experimental period, the 
animals were anesthetized with ether following a 12 hrs fasting period. 
Blood samples were drawn from the heart into microcentrifuge tube, 
and serum samples were obtained by centrifugation at 4000 ×g for 
15 minutes at 4°C. All animal experiments protocol were reviewed and 
approved by the Ethics Committee of Faculty of Medicine, Brawijaya 
University.
Physiological measurement
Daily food intake and fluid intake were measured every day, and body 
weight was measured every week. The food and fluid intake for each rat 
were measured by subtracting the provided amount by the remaining 
amounts in the cage.
Biochemical analysis
The serum concentrations of TG, HDL-cholesterol, and fasting glucose 
were measured enzymatically using commercial kits (Biolabo, France). 
Serum adiponectin and insulin levels were analyzed using enzyme-
linked immunosorbent assay method (Elabscience, China). The HOMA-
IR was used to calculate an index from the product of the fasting 
concentrations of plasma glucose (mg/dl) and insulin (µu/L) divided 
by 14.1. Lower HOMA-IR values indicate greater insulin sensitivity and 
higher HOMA-IR values indicate IR.
Blood pressure measurements
Blood pressure was measured using the tail-cuff method with 
sphygmomanometer technique at the baseline and at the end of the 
experiment. Three readings were taken consecutively, and the average 
was then calculated and taken as a final reading for SBP.
Statistical analysis
All data were analyzed with Statistical Package for Social Sciences 
(SPSS, version 22) and were presented as mean values with their 
standard deviation and subjected to one-way ANOVA, independent 
t-test, and pair t-test with significant p<0.05.
RESULT
Effect of GCE on changes in the body weight, food, and water intake
The body weight, food, and water intake of experimental rats were 
elevated during 7 weeks. However, at the end of study, no significant 
difference was observed in those variables among all groups as 
presented in Tables 1 and 2, respectively. Body weight increased 
significantly in 200 CGE group during 7-week intervention. Moreover, 
a significant food intake increase was observed in DMS group. 
Furthermore, a significant water intake increase was observed in all 
experimental groups during 7 weeks.
Effects of GCE on blood biochemistry
Effect of GCE on fasting blood glucose, TG, and HDL cholesterol on the 
experimental animals were presented in Tables 3 and 4. The level of 
fasting blood glucose TG and HDL was not statistically different among 
all groups at the baseline. Furthermore, after intervention for 7 weeks, 
a significant difference on fasting blood glucose, and TG level was 
observed in all interventional groups (p<0.05) compared to that of the 
baseline. At the end of study, a significant difference on fasting blood 
glucose and TG level was observed in GCE 100, GCE 200, and DMS group 
compared to that of MS group. The lowest blood fasting glucose level 
was observed in DMS and GCE 100 groups respectively. Moreover, the 
lowest TG level was observed DMS and GCE 200 group, respectively. No 
statistically different observed on HDL level among all interventional 
group.
Effect green coffee on blood pressure
GCE 100 and GCE 200 group showed a significant SBP decrease after 
intervention for seven weeks compared to that of the baseline. At the 
end of study, a significant lower SBP was observed in GCE 100 and GCE 
200 group compared to that of MS group (Table 4).
Effects of GCE on plasma adiponectin
Effect of GCE on plasma adiponectin level was presented in Fig. 1. GCE 
100 and GCE 200 group showed significantly higher adiponectin level 
compared to that of MS and DMS group. Moreover, administration of 
GCE at a dose of 100 mg/kg bw resulted in a slightly higher adiponectin 
level compared to that of 200 mg/kg bw.
Effects of GCE on HOMA-IR index
Effect of GCE on HOMA-IR index was presented in Fig. 2. GCE 100, 
GCE 200, and DMS group showed significantly lower HOMA-IR index 
compared to that of MS group. Moreover, GCE 100 group showed lower 
HOMA-IR index compared to that of GCE 200 group although it was 
not achieve any significant statistical difference. At the end of study, a 
significant different of HOMA-IR index was observed in GCE 100 and 
GCE 200 group compared to that of MS group (p<0.05).
DISCUSSION
A recent study was conducted in rat model that met the criteria 
of MS (hyperglicemia, elevated TG level, decreased HDL level, and 
Table 1: Effect of GCE on changes in the body weight of normal 
and MS rats




GCE 100 298.4±39.87 311±59.74
GCE 200 301±44.32 351.6±74#
DMS 318±30.05 318.8±44.07
Values are mean±SD, n=5. #Significant between baseline and after 
7 week (p<0.05). NC: Normal control, MS: Metabolic syndrome, GCE: Green 
coffee extract
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hypertension) as presented in baseline characteristics in Table 2. This 
study revealed that GCE 100 and GCE 200 administration improved 
MS. It was confirmed by high adiponectin level, low HOMA-IR index, 
significant reduction of blood glucose, TG, and SBP in GCE 100 and GCE 
200 group.
Adiponectin is a key molecule in the pathogenesis of MS [19]. In 
the present study, GCE improved metabolic profile of MS through 
adiponectin increase [20,21]. This study demonstrated a significantly 
higher adiponectin level in GCE 100 and GCE 200 compared to that of MS 
group. The adiponectin level also closed to that of NC group. This study 
was comparable with the previous study by Cho et al. that revealed a 
significantly higher adiponectin level after 8 weeks administration of 
0.02% CGA in diet compared to that of obese mice group [20]. Moreover, 
a study by Ong et al. suggested that 2 weeks treatment of CGA from 
green coffee bean improved serum adiponectin level in Leprdb/db mice 
compared to that of diabetic mice [10]. To the extent of our knowledge, 
this study was the first study that proved the benefit of CGE in MS rat.
Adiponectin level increasing effect by GCE was mediated by CGA induce 
transcriptional activity of peroxisome proliferator-activated receptor 
gamma (PPAR-γ). The previous study by Wu et al. showed that 200 
and 400 mg of CGA for 12 weeks increased transcriptional activity of 
PPAR-γ and consequently adiponectin level in ApoE-/- mice [22]. It was 
revealed that PPAR-γ affected adiponectin by controlling the expression 
of the adiponectin genes in adipose tissue. Moreover, adiponectin 
increasing effect was also shown in DMS group compared to that of 
MS group. Nevertheless, the effect of metformin and simvastatin only 
restoring the adiponectin level as high as NC group’s level. This result 
was consistent with the previous study that suggested metformin effect 
on restoring the adiponectin level as high as normal rat [23]. Thus, 
GCE administration demonstrated a better adiponectin increasing 
effect compared to that of 200 mg/kg bw metformin and 10 mg/kg bw 
simvastatin administration.
This study revealed that adiponectin level of GCE 100 was higher than 
that of GCE 200 although it was not achieve any statistical significance. 
In contrast, Choi et al. suggested that higher GCE dose resulted in higher 
adiponectin level [21]. The differences of substances composition 
Table 2: Effect of GCE on changes in food intake and fluid intake of normal and metabolic syndrome rats
Experimental groups Food intake (g) Fluid intake (ml)
Initial Final Initial Final
NC 21.82±1.48 26.85±1.9 33.86±0.77 20.31±1.1
MS 16.8±0.44 45.4±14.02 63.2±7.9# 18.4±2.5
GCE 100 18.2±1.48 45.2±4.88 66.4±4.92# 17.8±3.27
GCE 200 19.38±2.58 42.97±13.46 64.15±8.98# 20.03±5.12
DMS 18.87±2.54 41.81±9.02 59.48±7.42# 26.58±2.39#
Values are mean±SD, n=5. #Significant between baseline and after 7 week (p<0.05). NC: Normal control, MS: Metabolic syndrome, GCE: Green coffee extract, 
SD: Standard deviation
Fig. 1: Effect of green coffee bean on adiponectin level blood serum 
in normal control, metabolic syndrome (MS), DMS, green coffee 
extract (GCE) 100, and GCE 200 rats. Values are mean±standard 
deviation, n=5. *p<0.01, compared to the MS group and #p<0.05 
compared to the DMS group. NC: Normal control; MS: Metabolic 
syndrome induces; DMS: Metabolic syndrome treated with 
metformin and simvastatin; GCE 100: Metabolic syndrome with 
green coffee extract 100 mg/kg body weight (bw); GCE 200: 
Metabolic syndrome with green coffee extract 200 mg/kg bw
Table 3: Effect of GCE on changes in fasting blood glucose and TG of normal and metabolic syndrome rats
Experimental groups Fasting blood glucose (mg/dl) TG (mg/dl)
Initial Final Initial Final
NC 92.20±16.84 95.2±11.45 79.40±7.02 100±24.13
MS 255±29.72 270.2±40.18 281.80±25.97 261±67.12
GCE 100 260±26.16 186.20±11.10*# 281.40±142.76 153.40±15.79*#
GCE 200 247.80±29.21 201.20±11.3*# 262.40±62.91 146.8±14.94*#
DMS 248±28.67 178.40±59.94*# 296.40±30.51 158.2±42.31*#
Values are mean±SD, n=5. #Significant between baseline and after 7 week (p<0.05). *Significant compared to that of MS group (p<0.05). NC: Normal control, 
MS: Metabolic syndrome, TG: Triglyceride, SD: Standard deviation, GCE: Green coffee extract
Table 4: Effect of GCE on changes in HDL-cholesterol and SBP of normal and MS rats
Experimental groups HDL-cholesterol (mg/dl) SBP (mm/Hg)
Initial Final Initial Final
NC 44.40±3.13 44.80±3.03 125.2±5.16 126.8±6.41
MS 32.20±6.76 34±3.39 152.6±7.12 163±11.1
GCE 100 27.60±8.17 40.40±5.77# 152.6±3.84 145.4±3.43*#
GCE 200 34.60±5.45 39.20±2.86 152.4±7.40 147.0±8.03*#
DMS 29±8.09 43±7.07 158.4±1.94 157.2±1.78
Values are mean±SD, n=5. #Significant between baseline and after 7 weeks (p<0.05). *Significant compared to that of MS group (p<0.05). NC: Normal control, 
MS: Metabolic syndrome, SBP: Systolic blood pressure, SD: Standard deviation, HDL: High-density lipoprotein, GCE: Green coffee extract
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in the extract might contribute to this result. The extract used in 
our study was not purified, some caffeine and other polyphenols 
might contain in our extract on the other hand, Choi et al. used GCE 
contained 50% of caffeoylquinic acid (CQA) [21]. The chronic effect of 
higher GCE dose administration on homocysteine level might explain 
lower adiponectin level in higher GCE dose. The previous studies 
demonstrated that chronic administration of high-dose green coffee 
raised blood homocysteine level [24]. The mechanisms by which CGA 
raise plasma homocysteine are not clear. The previous study suggested 
that caffeine content in GCE might contribute significanly to the high 
level of homocystein. The previous study revealed that pure caffeine 
consumption increased homocysteine concentrations in healthy 
subjects [25,26]. However, caffeine from paper-filtered coffee only 
contributed to 25-50% of homocysteine increase compared to that of a 
similar amount of caffeine [25].
High homocystein level has been proved as a suppresor of adiponectin 
level. The previous study suggested that liver might affect adipocyte 
physiology through adipokines expression regulation through 
the secretion of metabolic molecules such as homocysteine [27]. 
The previous study clearly demonstrated that multiple pathways 
were involved in this mechanism. Homocysteine induced both 
inhibition of adiponectin gene expression in primary adipocytes and 
reduced circulating adiponectin levels in an animal model of mild 
hyperhomocysteinemia [27]. It revealed that elevated homocysteine 
in adipose tissue may play a causal role in suppressing adiponectin 
production.
Adiponectin also known as insulin sensitizer agent. The present study 
suggested that higher adiponectin negatively correlated with HOMA-IR 
index [14]. In our study, we assumed that higher adiponectin level led 
to lower HOMA-IR index. GCE 100 group who had higher adiponectin 
level showed lower HOMA-IR index compared to that of GCE 200 and 
DMS group. Although there was no significant, HOMA-IR difference 
among GCE 100, GCE 200, and DMS. The obtained HOMA-IR index by 
GCE 100 closed to that of NC group. These findings are consistent with 
previous reports that adiponectin functions as an insulin sensitizer 
by decreasing hepatic glucose output and thereby contributing to the 
regulation of whole-body glucose homeostasis [28]. Consistent with 
this, restoration of adiponectin levels in vivo by CGA from green coffee 
showed improvement of glycemia, insulin sensitivity, and fatty acid 
metabolism [29]. Moreover, it could have enhanced the activation of 
adenosine monophosphate-activated protein kinase (AMPK) through 
calmodulin-dependent protein kinase in muscle and liver [10] and 
upregulated AdipoR2 expression that resulted in insulin sensitivity 
modulation by stimulation of glucose utilization and fatty acid oxidation 
through phosphorylation [30]. These mechanisms were considered as 
beneficial effect of GCE in metabolic alterations.
Recently, this study showed that 100 mg/kg bw GCE was the effective 
dose in treating hyperglycemia, dyslipidemia in rat model of MS for 
7 weeks. The extent of GCE 100 mg/kg bw decreased fasting blood 
glucose, and TG level was also shown in GCE 200 mg/kg bw. However, 
the fasting blood glucose and TG level were slightly lower than GCE 
100 mg/kg bw. In contrast, the previous study by Shimoda showed that 
an oral administration of GCE (200 and 400 mg/kg day) for 13 days 
resulted in a tendency ofserum TG level reduction in mice [31]. Moreover, 
Choi et al. reported that an oral administration of GCE 100 and GCE 
200 in C57BL mice reduced serum glucose, TG level after 6 weeks, and 
significantly difference compare to that HFD group [21]. On the other 
hand, in significant serum HDL increase in GCE 100 and GCE 200 group 
was observed in this study. Antihyperglycemia and antidyslipidemia of 
GCE might be mediated by CGA activity. CGA affected AMPK signaling 
pathway [32], upregulated expression of adiponectin [10], upregulated 
adiponectin receptor gene [30], and increased transcriptional factor of 
PPAR-α [20] and PPAR-γ [21] which could regulate glucose and lipid 
metabolism.
A recent study revealed no body weight lowering effect after GCE 
administration for 7 weeks using both doses. This result was consistent 
with a study by Panchal et al. that showed no body weight lowering 
effect of 5% aqueous coffee extract oral administration for 8 weeks in 
MS rat model induced by HFD and high carbohydrate [33]. In contrast, 
other study revealed that GCE administration resulted in a tendency of 
visceral fat and body weight reduction. Song et al. suggested that the 
administration of 0.3% decaffeinated GCE for 11 weeks in HFD-fed mice 
resulted in body weight reduction [13]. Shimoda et al. also suggested 
that the administration of 0.5% and 1% GCE reduced visceral fat 
content and body weight.
The present study shows that GCE 100 and 200 mg/bw reduced blood 
pressure from 152.6±3.84 to 145.4±3.43 and 152.4±7.40 to 147.0±8.03, 
respectively. However, blood pressure increased was observed in 
MS group and DMS group. The blood pressure lowering effect of GCE 
was first reported in 2002 in spontaneus hypertensive rat (SHR) 
rat [34]. The previous study by Panchal et al. demonstrated that oral 
administration of 5% aqueous coffee extract after 8 weeks. SBP were 
reduced by 10-15 mmHg from baseline (measured by tail cuff), and the 
effect persisted through the end of the experiment [33]. As mentioned 
previously, GCE are rich in CGAs, with the principal form being 5-CQA. 
The presence of 5-CQA was hypothesized to promote SBP reduction. 
Both acute and chronic administration of 5-CQA showed almost 
identical results on SBP as seen in GCE administration on MS animal 
model diet induced. Furthermore, several mechanisms of SBP reduction 
by CGA and it metabolites such as, inhibition of nicotinamide adenine 
dinucleotide phosphate oxidase expression and activity, reduced free 
radical production, directly scavenging free radicals, stimulation of NO 
production by the endothelial-dependent pathway, and inhibition of 
angiotensin-converting enzyme in the plasma [35]. Hypotension effect 
of GCE could be influenced by roasting condition which that increase 
antioxidant activity [36].
Roasting effect on coffee can increase the antioxidant effect of 
polyphenols contained in coffee. Castillo et al. analyzed various roasted 
degree of coffee beansby gel filtration chromatography, ultraviolet-
visible spectrophotometry, capillary electrophoresis, and the 2,2′-azino-
bis(3-ethylbenzthiazoline-6-sulfonic acid) assay. It revealed that 
maximum antioxidant activity was observed inlight to medium roasted 
coffee; unroasted and dark coffee had significantly lower antioxidant 
activity compared to that of light to medium roasted coffee [11]. 
We assumed that this antioxidant activity increase contributed to 
antidiabetic, antidyslipidemia, and antihypertensive effect of GCE. 
However, we did not measure the antioxidant activity and composition 
our extract. Furthermore, as limitation of our study, we did not analyze 
another metabolic inflammation marker such as leptin, high-sensitivity 
C-reactive protein, AMPK activity, PPAR α, and PPAR γ gene expression; 
therefore, we cannot reveal GCE pathway on MS improvement. Further 
study regarding these issues is warranted.
Fig. 2: Effect of green coffee bean on homeostatic model 
assessment insulin resistance index in normal control (NC), 
metabolic syndrome (MS), DMS, green coffee extract (GCE) 100, 
and GCE 200 rats. Values are mean±standard deviation, n=5. 
*p<0.01 compared to the MS group. NC: Normal control; MS: 
Metabolic syndrome induces; DMS: Metabolic syndrome treated 
with metformin and simvastatin; GCE 100: Metabolic syndrome 
with green coffee extract 100 mg/kg. body weight (bw); GCE 200: 
Metabolic syndrome with green coffee extract 200 mg/kg.bw
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CONCLUSION
This study revealed the beneficial effect of light-roasted GCE 
administration on the improvement of adiponectin level, HOMA-IR 
index, lipid profile, fasting blood glucose level, and SBP in MS rat model.
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